Living with or without cyclins and cyclin-dependent kinases
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Entry into, progression through, and exit from the G1 phase of the mammalian cell cycle in response to extracellular mitogenic cues are presumed to be governed by cyclin-dependent kinases (Cdks) regulated by the D-type and E-type cyclins. Studies performed over more than a decade have supported the view that these holoenzymes are important, if not required, for these processes. However, recent experiments in which the genes encoding all three D-type cyclins, the two E-type cyclins, cyclin D-dependent Cdk4 and Cdk6, or cyclin E-dependent Cdk2 have been disrupted in the mouse germ line have revealed that much of fetal development occurs normally in their absence. Thus, none of these genes is strictly essential for cell cycle progression. To what extent is the prevailing dogma incorrect, and how can the recent findings be reconciled with past work?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the high frequency of mutations epistatically targeting the RB signaling pathway in cancer cells, inactivation of the individual cyclin D, Cdk4/6, and Ink4a genes in mice, while leading to specific developmental defects when disrupted alone or in combination, established that their functions were nonessential for the cell cycle per se (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it may well prove that mutations affecting other cell cycle regulators, such as amplification of cyclin E, loss of p27Kip1 or p21Cip1 and activation of CDK2 would bypass the requirement of tumor cells for CDK4/6 activity, thereby also conferring de novo resistance (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“…the idea that mutant " cancer stem cells, " rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance and, in turn, for resistance to therapy (Reya et al. 2001; Taipale and Beachy 2001; Al-Hajj et al. 2003).”
BackgroundStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738 · cited 2×
“The cells that give rise to many cancers have both the self-renewal and differentiating capacities of tissue stem cells, raising the idea that mutant “cancer stem cells,” rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance…”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundSelf-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“1994); conversely, attenuation of Cdk4 activity by polypeptide inhibitors of the INK4 gene family (Serrano et al. 1993) or by Cdk4-selective drugs (Tetsu and McCormick 2003) results in G1-phase arrest and cell cycle exit.”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243 · cited 6×
“1993), and by induction of polypeptide inhibitors of the Cip/Kip family in many physiologic settings (Sherr and Roberts 1995) result in G1-phase arrest.”
BackgroundInfluentialSelf-citationG1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674 · cited 1×
“If this occurs before the G1/S boundary, cells exit the cycle without replicating their DNA, but if it occurs afterward, cells complete mitosis and exit from the cycle in the next G1 interval (Matsushime et al. 1994; Sherr 1994).”
BackgroundSelf-citationCYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259 · cited 3×
“The relevant proteins include three D-type cyclins (D1, D2, and D3) that, in different combinations, bind to, and allosterically regulate, one of two Cdk subunits, Cdk4 and Cdk6, as well as the E-type cyclins (E1 and E2), which, in analogous fashion, govern the activity of a single catalytic subunit, Cdk2 (Morgan 1997…”
BackgroundInfluentialGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“…GSK-3, an enzyme that is inhibited by the phosphatidylinositol 3-kinase/AKT signaling pathway , in determining the stability of cyclin E implies that its life history, like that of cyclin D1 (Diehl et al. 1998), can be directly influenced by at least one mitogen-dependent kinase signaling cascade.”
BackgroundSelf-citationPolyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954 · cited 1×
“, two potent inhibitors of Cdk2 (Polyak et al. 1994; Reynisdottir et al. 1995; Sherr and Roberts 1995).”
Self-citationCyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614 · cited 2×
“In continuously dividing cells, cyclin D1 exits the cell nucleus during S phase, and its turnover is accelerated throughout this interval (Baldin et al. 1993; Diehl et al. 1998), but Rasdependent cyclin D1 synthesis and its stabilization in G2 phase allow it to reaccumulate before cells divide (Guo…”
Background
Research works printed but not linked: 1
- Resnitzky, D., Gossen, M., Bujard, H., and Reed, S.I. 1994. Ac- celeration of the G1/S phase transition by expression of cy- clins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669-1679.
Cited by
Items 101–200 of 1,000
Evolution of networks and sequences in eukaryotic cell cycle control
Cross, F. R., Buchler, N. E. G., & Skotheim, J. M. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0078 · Cited by 165
Autonomous Metabolic Oscillations Robustly Gate the Early and Late Cell Cycle
Papagiannakis, A., Niebel, B., Wit, E. C., & Heinemann, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.11.018 · Cited by 165
“First, cell-cycle entry can occur even in the absence of major cell-cycle machinery components (e.g., the early cyclins) (Sherr and Roberts, 2004).”
BackgroundBettess, M. D., Dubois, N., Murphy, M. J., Dubey, C., Roger, C., Robine, S., & Trumpp, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7868-7878.2005 · Cited by 150
“Recent genetic data obtained from mouse mutants lacking several components of the cell cycle machinery such as cyclins D1 to D3, cyclins E1 and E2, or CDKs 4 and 6 also suggest a more complex cell cycle regulation in vivo compared to what is known from studies in cultured cells (48).”
ResultCyclins: Roles in mitogenic signaling and oncogenic transformation: Mini Review
Musgrove, E. A. (2006) · Growth Factors · doi:10.1080/08977190500361812 · Cited by 149
Phylogenetic analysis of CDK and cyclin proteins in premetazoan lineages
Cao, L., Chen, F., Yang, X., Xu, W., Xie, J., & Yu, L. (2014) · BMC Evolutionary Biology · doi:10.1186/1471-2148-14-10 · Cited by 165
“In regard to CDK4 and CDK6, mice lacking Cdk4 or Cdk6 also exhibit different developmental anomalies [85,93-96], with mice lacking both CDK4 and CDK6 displaying progressive embryonic lethality from E14.”
BackgroundInfluentialConcise Review: Control of Cell Fate Through Cell Cycle and Pluripotency Networks
Boward, B., Wu, T., & Dalton, S. (2016) · Stem Cells · doi:10.1002/stem.2345 · Cited by 138
Santo, L., Vallet, S., Hideshima, T., Cirstea, D., Ikeda, H., Pozzi, S., Patel, K., Okawa, Y., Gorgun, G., Perrone, G., et al. (2010) · Oncogene · doi:10.1038/onc.2009.510 · Cited by 139
PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers
Li, Y., Chitnis, N., Nakagawa, H., Kita, Y., Natsugoe, S., Yang, Y., Li, Z., Wasik, M., Klein-Szanto, A. J. P., Rustgi, A. K., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0625 · Cited by 143
“Cyclin D1, together with its binding partners cyclin dependent kinase 4 and 6 (CDK4/6), forms an active complex that promotes cell cycle progression by phosphorylating and inactivating the retinoblastoma protein (14).”
Transforming Growth Factor-β-inducible Phosphorylation of Smad3
Wang, G., Matsuura, I., He, D., & Liu, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809281200 · Cited by 156
PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A
Patsoukis, N., Sari, D., & Boussiotis, V. A. (2012) · Cell Cycle · doi:10.4161/cc.22135 · Cited by 136
“In conjunction with cyclin E, Cdk2 phosphorylates p27kip1, resulting in ubiquitin-targeted degradation of p27kip1, which regulates not only cell cycle progression, but also cell motility and migration.28 Cdk2 promotes phosphorylation of Rb on specific sites, thereby reversing its ability to sequester E2F.23 Cdk2-media…”
BackgroundInfluentialRibes, V., Wang, Z., Dollé, P., & Niederreither, K. (2006) · Development · doi:10.1242/dev.02204 · Cited by 134
“D-cyclins are induced by mitogens and act as sensors of the extracellular environment that link mitogenic pathways to the core cell cycle machinery (reviewed by Sherr and Roberts, 2004).”
BackgroundPutting the brakes on the cell cycle: mechanisms of cellular growth arrest
Pack, L. R., Daigh, L. H., & Meyer, T. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.05.005 · Cited by 143
“majority of cells proliferate normally in mouse embryos lacking all three cyclin D proteins (D1−/−D2−/−D3−/−) or lacking cyclin E1 and E2 (E1−/−E2−/−) [4].”
Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21
Wang, Y., Fisher, J. C., Mathew, R., Ou, L., Otieno, S., Sublet, J., Xiao, L., Chen, J., Roussel, M. F., & Kriwacki, R. W. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.536 · Cited by 134
“This structural variability accounts for the functional diversity of Cdk–cyclin complexes that phosphorylate different sites on the same or different substrates at different times during cell divisio”
BackgroundCell Cycle Progression and Synchronization: An Overview
Wang, Z. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2736-5_1 · Cited by 158
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
Pivonello, R., Ferrigno, R., Martino, M. C. D., Simeoli, C., Paola, N. D., Pivonello, C., Barba, L., Negri, M., de Angelis, C., & Colao, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00648 · Cited by 147
PKR is activated by cellular dsRNAs during mitosis and acts as a mitotic regulator
Kim, Y., Lee, J. H., Park, J.-E., Cho, J., Yi, H., & Kim, V. N. (2014) · Genes & Development · doi:10.1101/gad.242644.114 · Cited by 132
Recent developments in cyclin-dependent kinase biochemical and structural studies
Echalier, A., Endicott, J., & Noble, M. E. M. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.10.002 · Cited by 148
“During G1, these complexes perform two important roles: the first a catalytic one in which they stimulate the expression of genes required for G1 progression by phosphorylation of the product of the retinoblastoma gene, pRB and the second a non-catalytic function in which they act as both sink and reservoir for member…”
Recent Findings in the Regulation of Programmed Death Ligand 1 Expression
Shen, X., Zhang, L., Li, J., Li, Y., Wang, Y., & Xu, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01337 · Cited by 139
Lee, J., Kanatsu-Shinohara, M., Morimoto, H., Kazuki, Y., Takashima, S., Oshimura, M., Toyokuni, S., & Shinohara, T. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.04.020 · Cited by 133
Protein kinase C signaling and cell cycle regulation
Black, A. R., & Black, J. D. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00423 · Cited by 125
“Several excellent reviews have been written on the regulation of the cell cycle (Sherr and Roberts, 2004; Cobrinik, 2005; Malumbres and Barbacid, 2005; Du and Pogoriler, 2006; Satyanarayana and Kaldis, 2009) and only a brief description will be given here.”
BackgroundMethodYuan, J., Krämer, A., Matthess, Y., Yan, R., Spänkuch, B., Gätje, R., Knecht, R., Kaufmann, M., & Strebhardt, K. (2005) · Oncogene · doi:10.1038/sj.onc.1209202 · Cited by 131
“…investigations provided unexpected results: the fetal development of the mice occurs normally, in which the genes encoding three D-type cyclins, or two E-type cyclins, or Cdk4 and Cdk6, or cyclin E-dependent Cdk2 have been disrupted in the germ lines (Sherr and Roberts, 2004).”
ResultA Two-Dimensional ERK-AKT Signaling Code for an NGF-Triggered Cell-Fate Decision
Chen, J.-Y., Lin, J.-R., Cimprich, K. A., & Meyer, T. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.11.023 · Cited by 127
Mitochondrial nitric oxide in the signaling of cell integrated responses
Carreras, M. C., & Poderoso, J. J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00248.2006 · Cited by 129
The Retinoblastoma Protein Regulates Pericentric Heterochromatin
Isaac, C. E., Francis, S. M., Martens, A. L., Julian, L. M., Seifried, L. A., Erdmann, N., Binné, U. K., Harrington, L., Sicinski, P., Bérubé, N. G., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3659-3671.2006 · Cited by 128
“been the cell type of choice in numerous cell cycle studies (51).”
BackgroundCytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin
Fusté, N. P., Fernández-Hernández, R., Cemeli, T., Mirantes, C., Pedraza, N., Rafel, M., Torres‐Rosell, J., Colomina, N., Ferrezuelo, F., Dolcet, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms11581 · Cited by 134
A common signature of cellular senescence; does it exist?
Sikora, E., Bielak-Żmijewska, A., & Mosieniak, G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101458 · Cited by 136
Tipping, A. J., Pina, C., Castor, A., Hong, D., Rodrigues, N. P., Lazzari, L., May, G. E., Jacobsen, S. E. W., & Enver, T. (2009) · Blood · doi:10.1182/blood-2008-06-161117 · Cited by 116
Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number
Sankaran, V. G., Ludwig, L. S., Sicinska, E., Xu, J., Bauer, D. E., Eng, J. C., Patterson, H. C., Metcalf, R. A., Natkunam, Y., Orkin, S. H., et al. (2012) · Genes & Development · doi:10.1101/gad.197020.112 · Cited by 122
Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo
Chen, H., Sun, B., Pan, S., Jiang, H., & Sun, X. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283212ade · Cited by 133
Cyclin E Constrains Cdk5 Activity to Regulate Synaptic Plasticity and Memory Formation
Odajima, J., Wills, Z. P., Ndassa, Y., Terunuma, M., Kretschmannova, K., Deeb, T. Z., Geng, Y., Gawrzak, S., Quadros, I. M., Newman, J., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.08.009 · Cited by 136
“Cyclin D-Cdk4/6 kinase phosphorylates the retinoblastoma protein, pRB, leading to the release of E2F transcription factors and to transcriptional induction of the E-type cyclins (cyclins E1 and E2) (Sherr and Roberts, 2004).”
BackgroundResultChondrocyte Proliferation and Differentiation
Wuelling, M., & Vortkamp, A. (2011) · Endocrine development · doi:10.1159/000328081 · Cited by 126
The structure of CDK4/cyclin D3 has implications for models of CDK activation
Takaki, T., Echalier, A., Brown, N. R., Hunt, T., Endicott, J. A., & Noble, M. E. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809674106 · Cited by 109
“This work further revealed that, although the CDK and cyclin families exhibit considerable functional redundancy, certain cell cycle CDKs have essential cell-type specific roles through their ability to phosphorylate specific substrates (3) or bind to specific cyclins (2).”
BackgroundEly, S., Di Liberto, M., Niesvizky, R., Baughn, L. B., Cho, H. J., Hatada, E. N., Knowles, D. M., Lane, J., & Chen-Kiang, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2159 · Cited by 115
Bilodeau, S., Roussel-Gervais, A., & Drouin, J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01885-08 · Cited by 116
“cyclin E-cdk2 is required for the G1/S transition and cyclins A and B together with cdk1 (cdc2) are required for G2/M progression (37).”
BackgroundInfluentialPilkinton, M. A., Sandoval, R., & Colamonici, O. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210562 · Cited by 132
Manganese Superoxide Dismutase Regulates a Redox Cycle Within the Cell Cycle
Sarsour, E. H., Kalen, A. L., & Goswami, P. C. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5303 · Cited by 122
“The cyclin D family (D1, D2, and D3) in combination with CDK4 and CDK6 facilitates the cells’ entry from the quiescent (G0) phase to the G1 phase of the proliferative cycle (80, 81).”
BackgroundMaudet, C., Mano, M., Ushasree, S., Sharan, M., Giacca, M., Förstner, K. U., & Eulálio, A. (2014) · Nature Communications · doi:10.1038/ncomms5718 · Cited by 113
Rossi, F., Ehlers, I., Agosti, V., Socci, N. D., Viale, A. J., Sommer, G., Yozgat, Y., Manova, K., Antonescu, C. R., & Besmer, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511076103 · Cited by 121
A mouse model for cyclin E-dependent genetic instability and tumorigenesis
Loeb, K. R., Kostner, H., Firpo, E. J., Norwood, T. H., Tsuchiya, K. D., Clurman, B. E., & Roberts, J. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.010 · Cited by 117
“Cyclin E1 associates predominantly with one member of the CDK family, Cdk2, and serves a dual purpose in activating cell proliferation: it phosphorylates and thereby inhibits proteins that impede cell cycle progression (p27Kip1, pRb), and it phosphorylates and thereby activates proteins that promote cell division (Hwa…”
BackgroundSelf-citationYin, P., Zhao, C., Li, Z., Mei, C., Yao, W., Liu, Y., Li, N., Qi, J., Wang, L., Shi, Y., et al. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.02.003 · Cited by 111
ARe we there yet? Understanding androgen receptor signaling in breast cancer
Michmerhuizen, A. R., Spratt, D. E., Pierce, L. J., & Speers, C. W. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-00190-9 · Cited by 118
Proteomic Identification of a Direct Role for Cyclin D1 in DNA Damage Repair
Jirawatnotai, S., Hu, Y., Livingston, D. M., & Sicinski, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3549 · Cited by 104
“binds and activates the cyclin-dependent kinases CDK4 and CDK6 (1).”
InfluentialPabla, N., Gibson, A. A., Buege, M., Ong, S. S., Li, L., Hu, S., Du, G., Sprowl, J. A., Vasilyeva, A., Janke, L. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424313112 · Cited by 114
“The enzymatic activity of CDKs is regulated by complex mechanisms that include posttranslational modifications and expression of activating and inhibitory proteins (1, 2, 6, 7).”
BackgroundVRK1 phosphorylates CREB and mediates CCND1 expression
Kang, T.-H., Park, D.-Y., Kim, W., & Kim, K.-T. (2008) · Journal of Cell Science · doi:10.1242/jcs.026757 · Cited by 108
“As a result, the CDKs formed by the association of D-type cyclins with CDK4 or CDK6 act as mitogen sensors during G1 phase to link signals from the extracellular environment to other CDKs comprising the core cell-cycle machinery (Sherr and Roberts, 2004).”
BackgroundHuman NDR Kinases Control G1/S Cell Cycle Transition by Directly Regulating p21 Stability
Cornils, H., Kohler, R. S., Hergovich, A., & Hemmings, B. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01216-10 · Cited by 104
“This process is initially controlled by the availability of the cyclin subunit, whose abundance is regulated by both transcriptional and posttranscriptional processes (44).”
BackgroundmTOR at the crossroads of T cell proliferation and tolerance
Mondino, A., & Mueller, D. L. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.02.008 · Cited by 108
Kennedy, A. L., Vallurupalli, M., Chen, L., Crompton, B. D., Cowley, G. S., Vázquez, F., Weir, B. A., Tsherniak, A., Parasuraman, S., Kim, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4903 · Cited by 115
“Deregulation of the cyclin D1/CDK4/6/Rb pathway leads to increased cell proliferation; this signaling axis is one of the most frequently mutated pathways in cancers [39].”
BackgroundCdk2 is required for p53-independent G2/M checkpoint control
Chung, J. H., & Bunz, F. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000863 · Cited by 105
Sohn, D., Graupner, V., Neise, D., Eßmann, F., Schulze‐Osthoff, K., & Jänicke, R. U. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.17 · Cited by 117
“However, participation of other cell-cycle regulatory proteins in addition to cyclin D1 cannot be ruled out, as there exists a high-functional redundancy between various cyclins and their CDKs.(40) In addition, modulation of cyclin/CDK protein levels might reciprocally influence expression of other cyclin/CDK complexe…”
Kim, T.-H., Goodman, J. F., Anderson, K. V., & Niswander, L. A. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.018 · Cited by 114
Systems biology of neutrophil differentiation and immune response
Theilgaard‐Mönch, K., Porse, B. T., & Borregaard, N. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.010 · Cited by 116
An update on the implications of cyclin D1 in oral carcinogenesis
Ramos‐García, P., Montoya, J. A. G., Scully, C. M., Ayén, Á., González‐Ruiz, L., Navarro‐Triviño, F. J., & González‐Moles, M. Á. (2017) · Oral Diseases · doi:10.1111/odi.12620 · Cited by 113
Aberrant Cell Cycle Regulation in Cervical Carcinoma
Kim, Y. T., & Zhao, M. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.5.597 · Cited by 114
“The E7 would deregulate pRb initially, unleashing E2F-induced cyclin E expression; the overexpressed CDK4 would tether the KIP molecules, allowing cyclin E to become sufficiently active to phosphorylate and inactivate pRb and p27, perpetuating its own activity and that of E7.”
BackgroundInfluentialPotapova, T., Daum, J. R., Byrd, K. S., & Gorbsky, G. J. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0771 · Cited by 103
“Vol. 20, March 15, 2009 1739 ( Sherr and Roberts, 2004 ), or by phosphorylation on inhibitory sites T14 and Y15 (Atherton-Fessler et al., 1994).”
BackgroundWuelling, M., & Vortkamp, A. (2009) · Pediatric Nephrology · doi:10.1007/s00467-009-1368-6 · Cited by 116
Zhang, X., Liu, D., Li, M., Cao, C., Wan, D., Xi, B., Li, W., Tan, J., Wang, J., Wu, Z., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0400-8 · Cited by 101
“D1, D2, and D3) are the first cyclins to be induced as cells enter the G1 phase of the cell cycle [34, 41, 42].”
Siegenthaler, J. A., & Miller, M. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1876-05.2005 · Cited by 113
Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies
Weinstein, S., Toker, I. A., Emmanuel, R., Ramishetti, S., Hazan-Halevy, I., Rosenblum, D., Goldsmith, M., Abraham, A., Benjamini, O., Bairey, O., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519273113 · Cited by 95
“Still, previous studies have shown that the compensatory activity of other D cyclins allows cycD1 knockout mice to be viable and to show only limited developmental defects (37).”
BackgroundControl of cellular senescence by CPEB
Groisman, I., Ivshina, M., Marin, V., Kennedy, N. J., Davis, R. J., & Richter, J. D. (2006) · Genes & Development · doi:10.1101/gad.1438906 · Cited by 94
“However, some genes that are important for cell cycle progression in cultured cells have little effect in KO mice (Sherr and Roberts 2004; Malumbres and Barbacid 2005).”
BackgroundThe Ciliary Margin Zone of the Mammalian Retina Generates Retinal Ganglion Cells
Marcucci, F., Murcia‐Belmonte, V., Wang, Q., Coca, Y., Ferreiro‐Galve, S., Kuwajima, T., Khalid, S., Ross, M. E., Mason, C. A., & Herrera, E. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.016 · Cited by 102
“Cyclin D2 is a member of the highly conserved cyclin family and integrates the Cyclin D2-CDK4 complex that phosphorylates and inhibits the retinoblastoma (Rb) protein (Sherr and Roberts, 2004).”
BackgroundLow Dose of Amino-Modified Nanoparticles Induces Cell Cycle Arrest
Kim, J. A., Åberg, C., de Cárcer, G., Malumbres, M., Salvati, A. L., & Dawson, K. A. (2013) · ACS Nano · doi:10.1021/nn403126e · Cited by 97
Pax9 and Jagged1 act downstream of Gli3 in vertebrate limb development
McGlinn, E., van Bueren, K. L., Fiorenza, S., Mo, R., Poh, A. M., Forrest, A. R. R., Soares, M. B., Bonaldo, M. F., Grimmond, S. M., Hui, C., et al. (2005) · Mechanisms of Development · doi:10.1016/j.mod.2005.06.012 · Cited by 104
Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation
Pogoriler, J. E., Millen, K. J., Utset, M. F., & Du, W. (2006) · Development · doi:10.1242/dev.02556 · Cited by 102
“As the D-type cyclins are known to be involved in the transition through G1 (Sherr and Roberts, 2004), we expected this phase of the cell cycle to be lengthened and the percentage of cells in S phase to be decreased.”
BackgroundA Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Guenther, L. M., Dharia, N. V., Ross, L. S., Conway, A. S., Robichaud, A. L., Catlett, J. L., Wechsler, C. S., Frank, E. S., Goodale, A. B., Church, A. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0372 · Cited by 100
“CDK4/6 inhibitors work by impairing the phosphorylation of Rb, thus inhibiting the proproliferative E2F transcriptional program and halting progression from the G1 to S phase of the cell cycle (40).”
Backgroundp73 Suppresses Polyploidy and Aneuploidy in the Absence of Functional p53
Talos, F., Nemajerová, A., Flores, E. R., Petrenko, O., & Moll, U. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.036 · Cited by 94
4-(Pyrazol-4-yl)-pyrimidines as Selective Inhibitors of Cyclin-Dependent Kinase 4/6
Cho, Y. S., Borland, M., Brain, C., Chen, C. H.-T., Cheng, H., Chopra, R., Chung, K., Groarke, J., He, G., Hou, Y., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100571n · Cited by 91
Cyclin D1 Splice Variants: Polymorphism, Risk, and Isoform-Specific Regulation in Prostate Cancer
Comstock, C. E. S., Augello, M. A., Benito, R. P., Karch, J., Tran, T. H., Utama, F. E., Tindall, E. A., Wang, Y., Burd, C. J., Groh, E. M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2865 · Cited by 92
“In many cell types, cyclin D1a promotes cell cycle progression through activation of cyclindependent kinases (CDK) 4 or 6 (3, 4).”
BackgroundAdon, A. M., Zeng, X., Harrison, M. K., Sannem, S., Kiyokawa, H., Kaldis, P., & Saavedra, H. I. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00253-09 · Cited by 101
“Cdk activities are positively regulated by association with different cyclins, which are temporally expressed at specific phases of the cell cycle; they are negatively regulated by a variety of Cdk inhibitors (CKIs) (65).”
BackgroundDiversity within the pRb pathway: is there a code of conduct?
Munro, S., Carr, S. M., & Thangue, N. B. L. (2012) · Oncogene · doi:10.1038/onc.2011.603 · Cited by 105
“Cyclin/Cdk complexes are themselves negatively regulated by Cdk inhibitors such as p16INK4A, p21CIP1 and p27KIP1 (Sherr and Roberts, 2004).”
BackgroundHuman Cdc45 is a proliferation‐associated antigen
Pollok, S., Bauerschmidt, C., Saenger, J., Nasheuer, H., & Große, F. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05900.x · Cited by 95
The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
García-Reyes, B., Kretz, A.-L., Ruff, J.-P., von Karstedt, S., Hillenbrand, A., Knippschild, U., Henne‐Bruns, D., & Lemke, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103219 · Cited by 102
“CDK2/Cyclin E complexes act mainly in the G1 and S phases of the cell cycle [96], however, its levels are reduced after the early stages of the S phase by proteasomal degradation.”
BackgroundLoddo, M., Kingsbury, S. R., Rashid, M., Proctor, I., Holt, C., Young, J., Sheikh, S. E., Falzon, M., Eward, K. L., Prevost, T. C., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604924 · Cited by 100
“Most cell cycles contain additional gap phases between S and M phases, which provide additional time for growth and also serve as important regulatory transitions, through which progression to the next cellcycle stage can be controlled by intracellular and extracellular signals (Nigg, 2001; Sherr and Roberts, 2004) (F…”
BackgroundLi, L., Iwamoto, Y., Berezovskaya, A., & Boussiotis, V. A. (2006) · Nature Immunology · doi:10.1038/ni1398 · Cited by 102
“The cyclin-dependent kinase (Cdk) inhibitor p27 Kip1 is a member of the 'Cip-Kip' family of Cdk inhibitors and has been reported to interact with Cdk2, the adapter Grb2, and Rho family GTPase”
Congenital Heart Disease–Causing Gata4 Mutation Displays Functional Deficits In Vivo
Misra, C., Sachan, N., McNally, C. R., Koenig, S. N., Nichols, H. A., Guggilam, A., Lucchesi, P. A., Pu, W. T., Srivastava, D., & Garg, V. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002690 · Cited by 87
“mutation results in myocardial hypoplasia due to diminished cardiac proliferation. This phenotype is at least partially mediated by reduced expression of cyclin D2, a member of the D-cyclin family of cell cycle regulators. Mice lacking any single D-cyclin are viable and do not display obvious cardiac defects”
BackgroundSelective cortical interneuron and GABA deficits in cyclin D2-null mice
Glickstein, S. B., Moore, H., Slowinska, B., Racchumi, J., Suh, M., Chuhma, N., & Ross, M. E. (2007) · Development · doi:10.1242/dev.008524 · Cited by 89
“Cyclin D1/D2 effects on the cell cycle are complex and neither is strictly required for cell cycle progression (Kozar et al., 2004; Sherr, 2000; Sherr and Roberts, 2004).”
BackgroundThe Hippo Signaling Pathway in Drug Resistance in Cancer
Zeng, R., & Dong, J. (2021) · Cancers · doi:10.3390/cancers13020318 · Cited by 89
MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α
Chen, S., Sun, K.-X., Liu, B.-L., Zong, Z.-H., & Zhao, Y. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0496-4 · Cited by 89
“During late G1 phase, the CDK2/cyclin E complexes regulate the G1 to S phase transition and the CDK2/cyclin A complexes play an important role in S phase progression [40, 41].”
Brain‐derived neurotrophic factor induces proliferation of human airway smooth muscle cells
Aravamudan, B., Thompson, M., Pabelick, C. M., & Prakash, Y. S. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01356.x · Cited by 91
“Increased Cyclin E and decreased p27Kip1 abundance are thus indicative of cell cycle progression from G1 or quiescence phase [26,27].”
BackgroundMYC and the Control of DNA Replication
Dominguez-Sola, D., & Gautier, J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014423 · Cited by 85
Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned?
Alshamrani, A. A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01084 · Cited by 92
Mayr, D. C., Kanitz, V., Anderegg, B., Luthardt, B., Engel, J., Löhrs, U., Amann, G., & Diebold, J. (2006) · American Journal of Clinical Pathology · doi:10.1309/n6x5mb24bp42kp20 · Cited by 97
A dual role of Cdk2 in DNA damage response
Ande, S., & Kaldis, P. (2009) · Cell Division · doi:10.1186/1747-1028-4-9 · Cited by 92
“Under normal circumstances, Dtype cyclins activate Cdk4 and/or Cdk6 and initiate phosphorylation of Retinoblastoma protein (Rb) family early in the G1 phase [2,3].”
BackgroundBackes, A. C., Zech, B., Felber, B., Klebl, B., & Müller, G. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460440802579975 · Cited by 92
“The same cyclin-dependent protein kinase (CDK) subtype is associated with different subclasses of cyclins during different stages of the cell cycle, thus resulting in different activities [21] .”
BackgroundToll-like Receptor Signaling Stimulates Cell Cycle Entry and Progression in Fibroblasts
Hasan, U. A., Trinchieri, G., & Vlach, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500877200 · Cited by 99
Impact of differential cyclin D1 expression and localisation in prostate cancer
Comstock, C. E. S., Revelo, M. P., Buncher, C. R., & Knudsen, K. E. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603615 · Cited by 91
“This class of cyclins interact with and activate cyclin-dependent kinases (CDK) 4/6 to promote G1 progression during the cell cycle (Mittnacht, 1998; Sherr and Roberts, 2004).”
BackgroundKono, A., Umeda‐Hara, C., Adachi, S., Nagata, N., Konomi, M., Nakagawa, T., Uchimiya, H., & Umeda, M. (2007) · The Plant Cell · doi:10.1105/tpc.106.046763 · Cited by 87
“Mitogen-induced signals stimulate cyclin D-CDK complexes at multiple levels, including those of gene transcription, translation, protein stability, and assembly and import of these complexes into the nucleus (Sherr and Roberts, 2004).”
BackgroundXiong, R., Zhao, J., Gutgesell, L. M., Wang, Y., Lee, S., Karumudi, B., Zhao, H., Lu, Y., Tonetti, D. A., & Thatcher, G. R. J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01355 · Cited by 110
Sedlmeier, E.-M., Brunner, S., Much, D., Pagel, P., Ulbrich, S. E., Meyer, H. H., Amann-Gassner, U., Hauner, H., & Bader, B. L. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-941 · Cited by 80
“CDK6 and PCNAmRNA levels correlated with offspring birth weight and birth weight percentiles.”
BackgroundInfluentialC. elegans cell cycles: invariance and stem cell divisions
Kipreos, E. T. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1738 · Cited by 95
“Recent studies in mice have shown that neither cyclin D–CDK4/CDK6 nor cyclin E–CDK2 are required for cell-cycle progression in most tissues, with organs developing surprisingly normally in embryos that lack either class of cyclin–CDK complexe”
BackgroundWang, W., Taylor, R. N., Bagchi, I. C., & Bagchi, M. K. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1169 · Cited by 90
APC/C and SCF cyclin F Constitute a Reciprocal Feedback Circuit Controlling S-Phase Entry
Choudhury, R., Bonacci, T., Arceci, A., Lahiri, D., Mills, C. A., Kernan, J. L., Branigan, T. B., DeCaprio, J. A., Burke, D. J., & Emanuele, M. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.058 · Cited by 88
“The best studied of these are Cyclins, the activating subunits of Cyclin Dependent Kinases (CDKs).”
InfluentialAt the crossroads: diverse roles of early thymocyte transcriptional regulators
Anderson, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00352.x · Cited by 85
“Cyclin D3-associated kinases can phosphorylate Rb, inactivating it, and can also inactivate p21 and p27 by sequestering them (163).”
BackgroundThe cell cycle and pluripotency
Hindley, C. J., & Philpott, A. (2013) · Biochemical Journal · doi:10.1042/bj20121627 · Cited by 91
Cellular basis of neuroepithelial bending during mouse spinal neural tube closure
McShane, S. G., Molè, M. A., Savery, D., Greene, N. D. E., Tam, P., & Copp, A. J. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.06.003 · Cited by 82
Hong, Y., Wang, D., Lin, Y., Yang, Q., Wang, Y., Xie, Y., Shu, W., Gao, S., & Hua, C. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117352 · Cited by 81
Critical requirement for cell cycle inhibitors in sustaining nonproliferative states
Pajalunga, D., Mazzola, A., Salzano, A. M., Biferi, M. G., De Luca, G., & Crescenzi, M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200608109 · Cited by 77
“This result is in keeping with the notion that ordinarily, the activation of cdk2 is preceded by and is partially dependent on previous cdk4/6 fi ring (Sherr and Roberts, 2004).”
BackgroundResultInfluentialStengel, A., Kern, W., Zenger, M., Perglerová, K., Schnittger, S., Haferlach, T., & Haferlach, C. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22313 · Cited by 83
Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy
Pienta, K. J., Hammarlund, E. U., Austin, R. H., Axelrod, R., Brown, J. S., & Amend, S. R. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.016 · Cited by 83
Chen, H., Sun, B., Wang, S., Pan, S., Gao, Y., Bai, X., & Xue, D. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0731-0 · Cited by 79
“The complexes responsible for the progression of cells through the G1 phase of cell cycle and initiation of DNA replication include cyclin D–cdk4/ cdk6 and cyclin E–cdk2 complexes (Sherr and Roberts 2004).”
BackgroundCooperation between Cyclin E and p27Kip1 in Pituitary Tumorigenesis
Roussel-Gervais, A., Bilodeau, S., Vallette-Kasic, S., Berthelet, F., Lacroix, A., Figarella‐Branger, D., Brue, T. C., & Drouin, J. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0091 · Cited by 81
Metadata
- Authors
- Sherr, C. J., & Roberts, J. M.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-11-15
- Volume
- 18
- Issue
- 22
- Pages
- 2699-2711
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2152107294
- Cited by
- 1,089
- References
- 115
- Citations by year
- 2026: 13 · 2025: 36 · 2024: 48 · 2023: 38 · 2022: 34 · 2021: 42 · 2020: 49 · 2019: 50 · 2018: 36 · 2017: 35 · 2016: 42 · 2015: 51 · 2014: 47 · 2013: 52 · 2012: 62
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- cyclin-dependent kinases, cyclins, D-type cyclins, G1 phase, cell cycle progression, CDK4, CDK6, CDK2, cyclin E, cyclin D, fetal development, mitogenic signaling
- MeSH terms
- Animals, Cell Cycle, Humans, Signal Transduction, Cyclins, Mice, Knockout, Cyclin-Dependent Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.